FRESENIUS MEDICAL CARE AG Purchase Of Treasury Shares
FRESENIUS MEDICAL CARE AG (FMS) reported Purchase Of Treasury Shares of EUR 586.09 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Notes
ifrs-full:PurchaseOfTreasuryShares · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG purchase of treasury shares for the quarter ending 2025-12-31 was -13.91M EUR.
- FRESENIUS MEDICAL CARE AG purchase of treasury shares for the quarter ending 2020-12-31 was 0.00 EUR, a 100.00% decline year-over-year.
- FRESENIUS MEDICAL CARE AG purchase of treasury shares for the quarter ending 2020-09-30 was 0.00 EUR, a 100.00% decline year-over-year.
- FRESENIUS MEDICAL CARE AG purchase of treasury shares for the quarter ending 2020-06-30 was 43.82M EUR, a 76.92% decline year-over-year.
| Period end | Purchase Of Treasury Shares 3 month | Purchase Of Treasury Shares 6 month | Purchase Of Treasury Shares 9 month | Purchase Of Treasury Shares 12 month |
|---|---|---|---|---|
| 2025-12-31 | -13.91M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 586.09M EUR 20-F · filed 2026-02-24 | ||
| 2025-09-30 | 600.00M EUR 6-K · filed 2025-11-04 | |||
| 2020-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-22 | 0.00 EUR derived: sum of 2 quarters · filed 2023-02-22 | 43.82M EUR derived: sum of 3 quarters · filed 2023-02-22 | 365.99M EUR 20-F · filed 2023-02-22 |
| 2020-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | 43.82M EUR derived: sum of 2 quarters · filed 2021-11-02 | 365.99M EUR 6-K · filed 2021-11-02 | 497.38M EUR derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | 43.82M EUR derived: 6-K 6 month − 6-K 3 month · filed 2021-07-30 | 365.99M EUR 6-K · filed 2021-07-30 | 497.38M EUR derived: sum of 3 quarters · filed 2022-02-22 | 651.63M EUR derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | 322.16M EUR 6-K · filed 2021-05-06 | 453.56M EUR derived: sum of 2 quarters · filed 2022-02-22 | 607.80M EUR derived: sum of 3 quarters · filed 2022-02-22 | 797.65M EUR derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | 131.40M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-02-22 | 285.64M EUR derived: sum of 2 quarters · filed 2022-02-22 | 475.49M EUR derived: sum of 3 quarters · filed 2022-02-22 | 589.30M EUR 20-F · filed 2022-02-22 |
| 2019-09-30 | 154.24M EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-10-29 | 344.09M EUR derived: sum of 2 quarters · filed 2020-10-29 | 457.91M EUR 6-K · filed 2020-10-29 | 457.91M EUR derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | 189.85M EUR derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | 303.67M EUR 6-K · filed 2020-07-30 | 303.67M EUR derived: sum of 3 quarters · filed 2021-02-23 | |
| 2019-03-31 | 113.82M EUR 6-K · filed 2020-05-06 | 113.82M EUR derived: sum of 2 quarters · filed 2021-02-23 | ||
| 2018-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-02-23 | 37.22M EUR 20-F · filed 2021-02-23 | ||
| 2018-09-30 | 37.22M EUR 6-K · filed 2019-10-31 | |||
| 2017-12-31 | 57.94M EUR 20-F · filed 2020-02-20 |